# HIV/AIDS Clinical Trials Unit (CTU) COVID-19 Admin Supplement

> **NIH NIH UM1** · UNIV OF NORTH CAROLINA CHAPEL HILL · 2020 · $600,000

## Abstract

Project Summary/Abstract
The University of North Carolina (UNC) Global HIV Clinical Trials Unit (CTU) has a well
established track record of high-quality, innovative clinical research, strong scientific leadership
(both in and outside the NIH HIV/AIDS Networks), and access to critically important infected and
at-risk populations in the Southeastern US, Southeast Asia and in Southern Africa. Drawn from
a diverse team of clinical innvestigators spanning two continents, our is led by experienced
principal investigators (Joseph Eron MD and Mina Hosseinipour MD) and will support all 5 NIH
HIV Clinical Trials Networks: Adult Therapeutic Strategies, Strategies to Address HIV and HIV-
associated Infections in Pediatric and Maternal Populations, Integrated HIV Prevention
Strategies, Microbicide Strategies, and Vaccine Strategies to Prevent HIV Infection. The Clinical
Research Sites (CRS) include Chapel Hill CRS led by David Wohl MD (Adult Therapeutic
Strategies, Integrated Prevention, Microbicide and Vaccine), Greensboro CRS led by Cornelius
Van Dam MD PhD (Adult Therapeutic Strategy and Integrated Prevention), Malawi CRS led by
Lameck Chinula MD (all 5 Networks) and Vietnam (protocol specific site) led by Vivian Go.
Supporting this leadership is a well-organized research team, comprising global experts and site
collaborators who will work to execute the network scientific agendas. The CTU has also
assembled a diverse group of senior scientists and public health officials to serve on our
Scientific and Strategic Advisory Group. The CTU administration incorporates a highly
organized structure that will be responsive to our experienced research teams across the CRS
and will provide ongoing evaluation to ensure optimal performance and efficiency. The CTU is
supported by state-of-the-art communications and outstanding laboratory, pharmacy, quality
assurance, data management and regulatory support. With its robust administrative framework,
the UNC Global HIV CTU is optimally positioned to provide scientific leadership and clinical
trials infrastructure to advance the field of agenda of the NIAID HIV networks and emerging
infectious disease such as the SARS-CoV-2 pandemic.

## Key facts

- **NIH application ID:** 10166401
- **Project number:** 3UM1AI069423-14S1
- **Recipient organization:** UNIV OF NORTH CAROLINA CHAPEL HILL
- **Principal Investigator:** Joseph J Eron
- **Activity code:** UM1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $600,000
- **Award type:** 3
- **Project period:** 2020-06-01 → 2022-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10166401

## Citation

> US National Institutes of Health, RePORTER application 10166401, HIV/AIDS Clinical Trials Unit (CTU) COVID-19 Admin Supplement (3UM1AI069423-14S1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10166401. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*